AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca property, plant and equipment (PP&E) — net carrying value ($M) ($M)
Form 20-F Note 8 & Note 29 — Property, Plant & Equipment by Class & Geography
Latest, Q2 2026
13,615
Period ended Jun 30, 2026
Change on a year earlier
+17.0%
11,637 in Q2 2025
History
21 quarters
Since Q4 2015
Sources
18
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Property, plant and equipment (PP&E) — net carrying value ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 13,615 | +17.0% | Form 6-K (filed 2026-07-27) ↗ |
| Q4 2025 | Dec 31, 2025 | 12,962 | +26.4% | Form 20-F (filed 2026-02-24) ↗ |
| Q2 2025 | Jun 30, 2025 | 11,637 | +20.8% | Form 6-K (filed 2025-07-29) ↗ |
| Q4 2024 | Dec 31, 2024 | 10,252 | +9.0% | Form 20-F (filed 2025-02-18) ↗ |
| Q2 2024 | Jun 30, 2024 | 9,630 | +11.0% | Form 6-K (filed 2024-07-25) ↗ |
| Q4 2023 | Dec 31, 2023 | 9,402 | +10.5% | Form 20-F (filed 2024-02-20) ↗ |
| Q2 2023 | Jun 30, 2023 | 8,675 | -0.5% | Form 6-K (filed 2023-07-28) ↗ |
| Q4 2022 | Dec 31, 2022 | 8,507 | -7.4% | Form 20-F (filed 2023-02-21) ↗ |
| Q2 2022 | Jun 30, 2022 | 8,722 | +4.4% | Form 6-K (filed 2022-07-29) ↗ |
| Q4 2021 | Dec 31, 2021 | 9,183 | +11.3% | Form 20-F (filed 2022-02-22) ↗ |
| Q2 2021 | Jun 30, 2021 | 8,357 | +11.8% | Form 6-K (filed 2021-07-30) ↗ |
| Q4 2020 | Dec 31, 2020 | 8,251 | +7.3% | Form 20-F (filed 2021-02-16) ↗ |
| Q2 2020 | Jun 30, 2020 | 7,475 | +0.4% | Form 6-K/A (filed 2020-07-31) ↗ |
| Q4 2019 | Dec 31, 2019 | 7,688 | +3.6% | Form 20-F (filed 2020-03-03) ↗ |
| Q2 2019 | Jun 30, 2019 | 7,442 | -1.0% | Form 6-K (filed 2019-07-25) ↗ |
| Q4 2018 | Dec 31, 2018 | 7,421 | -2.5% | Form 20-F (filed 2019-03-05) ↗ |
| Q2 2018 | Jun 30, 2018 | 7,514 | +6.1% | Form 6-K (filed 2018-07-26) ↗ |
| Q4 2017 | Dec 31, 2017 | 7,615 | +11.2% | Form 20-F (filed 2018-03-06) ↗ |
| Q2 2017 | Jun 30, 2017 | 7,079 | – | Form 6-K (filed 2018-07-26) ↗ |
| Q4 2016 | Dec 31, 2016 | 6,848 | +6.8% | Form 20-F (filed 2018-03-06) ↗ |
| Q4 2015 | Dec 31, 2015 | 6,413 | – | Form 20-F (filed 2018-03-06) ↗ |
Breakdown
What makes up property, plant and equipment (pp&e) — net carrying value ($m)
- Land and buildings — net carrying value ($M)–
- Plant and equipment — net carrying value ($M)–
- Assets in course of construction (CIP) ($M)–
- Gross PP&E cost ($M)–
- Accumulated depreciation & impairment of PP&E ($M)–
- PP&E in United States ($M)–
- PP&E in United Kingdom ($M)–
- PP&E in Sweden ($M)–
- PP&E in Ireland ($M)–
- PP&E in Rest of World ($M)–
Cite this data
StockData. (2026). AstraZeneca Property, plant and equipment (PP&E) — net carrying value ($M) ($M), quarterly Q4 2015–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/ppe_net_total
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.